Literature DB >> 21809180

Does sustained weight loss reverse the metabolic syndrome?

Annie Ferland1, Robert H Eckel.   

Abstract

The prevalence of the metabolic syndrome (MetS) has increased rapidly in North America in recent years. Presently, the MetS is found in 34.3% of the population, and the prevalence is likely to continue to increase in parallel with the obesity epidemic. Losing weight and long-term maintenance of the weight loss are primary targets to beneficially reverse all of the components of the MetS. This paper reviews the clinical and experimental evidence for the reversal of the metabolic complications related to the MetS that follows a sustained weight loss.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21809180     DOI: 10.1007/s11906-011-0221-z

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  91 in total

1.  Amount of food group variety consumed in the diet and long-term weight loss maintenance.

Authors:  Hollie A Raynor; Robert W Jeffery; Suzanne Phelan; James O Hill; Rena R Wing
Journal:  Obes Res       Date:  2005-05

2.  Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Leonelo Bautista; Maria Grazia Franzosi; Patrick Commerford; Chim C Lang; Zvonko Rumboldt; Churchill L Onen; Liu Lisheng; Supachai Tanomsup; Paul Wangai; Fahad Razak; Arya M Sharma; Sonia S Anand
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

4.  The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

Authors:  Trevor J Orchard; Marinella Temprosa; Ronald Goldberg; Steven Haffner; Robert Ratner; Santica Marcovina; Sarah Fowler
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

5.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

6.  Meta-analysis: surgical treatment of obesity.

Authors:  Melinda A Maggard; Lisa R Shugarman; Marika Suttorp; Margaret Maglione; Harvey J Sugerman; Harvey J Sugarman; Edward H Livingston; Ninh T Nguyen; Zhaoping Li; Walter A Mojica; Lara Hilton; Shannon Rhodes; Sally C Morton; Paul G Shekelle
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

7.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

8.  Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association.

Authors:  John P Bantle; Judith Wylie-Rosett; Ann L Albright; Caroline M Apovian; Nathaniel G Clark; Marion J Franz; Byron J Hoogwerf; Alice H Lichtenstein; Elizabeth Mayer-Davis; Arshag D Mooradian; Madelyn L Wheeler
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

9.  Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program.

Authors:  R Stamler; J Stamler; R Grimm; F C Gosch; P Elmer; A Dyer; R Berman; J Fishman; N Van Heel; J Civinelli
Journal:  JAMA       Date:  1987-03-20       Impact factor: 56.272

10.  Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.

Authors:  M H Davidson; J Hauptman; M DiGirolamo; J P Foreyt; C H Halsted; D Heber; D C Heimburger; C P Lucas; D C Robbins; J Chung; S B Heymsfield
Journal:  JAMA       Date:  1999-01-20       Impact factor: 56.272

View more
  6 in total

1.  Evaluation of health promotion programmes in severe mental illness: theory and practice.

Authors:  Fenneke M van Hasselt; Paul F M Krabbe; Maarten J Postma; Anton J M Loonen
Journal:  Int J Methods Psychiatr Res       Date:  2014-12-09       Impact factor: 4.035

2.  Synovial fibroblast-derived exosomal microRNA-106b suppresses chondrocyte proliferation and migration in rheumatoid arthritis via down-regulation of PDK4.

Authors:  Dan Liu; Yuxuan Fang; Yujun Rao; Wei Tan; Wei Zhou; Xia Wu; Chunwang Zhang; Yu Zhang; Yanqing Liu; Masataka Sunagawa; Tadashi Hisamitsu; Guoqing Li
Journal:  J Mol Med (Berl)       Date:  2020-02-20       Impact factor: 4.599

3.  Excess body mass index loss predicts metabolic syndrome remission after gastric bypass.

Authors:  Mário Nora; Marta Guimarães; Rui Almeida; Paulo Martins; Gil Gonçalves; Mariana Santos; Tiago Morais; Cláudia Freitas; Mariana P Monteiro
Journal:  Diabetol Metab Syndr       Date:  2014-01-02       Impact factor: 3.320

4.  GSH levels affect weight loss in individuals with metabolic syndrome and obesity following dietary therapy.

Authors:  Nikolaos Goutzourelas; Marina Orfanou; Ioannis Charizanis; George Leon; Demetrios A Spandidos; Demetrios Kouretas
Journal:  Exp Ther Med       Date:  2018-05-23       Impact factor: 2.447

Review 5.  Lifestyle Modification in the Management of Metabolic Syndrome: Statement From Korean Society of CardioMetabolic Syndrome (KSCMS).

Authors:  Hack-Lyoung Kim; Jaehoon Chung; Kyung-Jin Kim; Hyun-Jin Kim; Won-Woo Seo; Ki-Hyun Jeon; Iksung Cho; Jin Joo Park; Min-Ho Lee; Jon Suh; Sang-Yup Lim; Seonghoon Choi; Sang-Hyun Kim
Journal:  Korean Circ J       Date:  2022-02       Impact factor: 3.243

6.  Weight changes in hypertensive patients with phlegm-dampness syndrome: an integrated proteomics and metabolomics approach.

Authors:  Chi Zhang; Li Li; Shiping Cheng; Debajyoti Chowdhury; Yong Tan; Xinru Liu; Ning Zhao; Xiaojuan He; Miao Jiang; Cheng Lu; Aiping Lyu
Journal:  Chin Med       Date:  2021-07-07       Impact factor: 5.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.